Elixir Biopharma LLP - paper in Indore, Madhya Pradesh, India. Directors, charges & compliance details.
LLPIN ACC-8999 Incorporated 06 September 2023 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Limited Liability Partnership paper
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
3 yrs
Est. 2023
Designated partners
3
As per MCA filings
Last financials
Mar 2024
Balance sheet date
LLP status
Active
MCA master data
Registrar
Gwalior
ROC office
Incorporated
06 Sep 2023
Date of incorporation
Entity type
LLP
As registered with MCA

About Elixir Biopharma LLP

Data last updated:

Elixir Biopharma LLP is a limited liability partnership (LLP) based in Indore, Madhya Pradesh, India. It operates in the manufacturing segment of the paper and packaging sector. It was incorporated on 06 September 2023.

The LLP is registered with the Registrar of Companies (ROC), Gwalior, under LLPIN ACC-8999.

The LLP has a total obligation of contribution of β‚Ή1 Lakh. It is led by designated partners including Jayesh Gujarati and Vivek Kumar Dammani.

Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Indore, Madhya Pradesh.

Company details

LLPIN ACC-8999
Incorporation Date 06 September 2023
Total Obligation of Contribution β‚Ή1 Lakh
ROC Gwalior
Company Status Active

Contact details

Elixir Biopharma LLP's registered office is in Indore, Madhya Pradesh.

  • Registered Address
    208 Chetak Center 12/2 Rnt, Marg Near Hotel Shreemaya, Indore, Madhya Pradesh, India – 452001
  • Industry
    Paper, Manufacturing, Paper & Paper Products
Comprehensive company report
Elixir Biopharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Elixir Biopharma LLP

FY 2024 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2023-24
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2023-24
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Elixir Biopharma LLP, buy the company report.

Designated partners of Elixir Biopharma LLP

Elixir Biopharma has 3 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Jayesh GujaratiDesignated Partner06 Sep 20233 Years 2 MonthsCurrent
Vivek Kumar DammaniDesignated Partner06 Sep 20233 Years 2 MonthsCurrent
Smit ShahDesignated Partner06 Sep 20233 Years 2 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Elixir Biopharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Elixir Biopharma LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Elixir Biopharma LLP has 3 designated partner changes on record since 2023: 3 appointments. The latest: Jayesh Gujarati was appointed as Designated Partner on 06 Sep 2023.

AGM
Elixir Biopharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Elixir Biopharma Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
Appointed
Jayesh Gujarati was appointed as Designated Partner.
Appointed
Smit Shah was appointed as Designated Partner.
Appointed
Vivek Kumar Dammani was appointed as Designated Partner.
Incorporation
06 Sep 2023
Elixir Biopharma Llp was registered on 06 Sep 2023 with Roc Gwalior & aged 3 years 2 months as per MCA records.

Frequently asked questions

Elixir Biopharma is an active limited liability partnership based in Indore, Madhya Pradesh, India. The LLP works in manufacturing, within the paper industry. It was incorporated on 06 September 2023 (3+ years old) and is registered under LLPIN ACC-8999.

Elixir Biopharma has 3 current designated partners:

The latest financial statements of Elixir Biopharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2024 are in the company report.

The LLPIN (Limited Liability Partnership Identification Number) of Elixir Biopharma is ACC-8999. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Elixir Biopharma was incorporated on 06 September 2023, making it 3+ years old. It is registered with the Registrar of Companies, Gwalior.

Jayesh Gujarati was appointed as Designated Partner on 06 Sep 2023. Smit Shah was appointed as Designated Partner on 06 Sep 2023. Vivek Kumar Dammani was appointed as Designated Partner on 06 Sep 2023.

The registered office of Elixir Biopharma is at 208 Chetak Center 122 Rnt, Marg Near Hotel Shreemaya, Indore, Madhya Pradesh, India – 452001.

Elixir Biopharma operates in the paper industry, in the manufacturing segment.

Elixir Biopharma can be reached at its registered office: 208 Chetak Center 122 Rnt, Marg Near Hotel Shreemaya, Indore, Madhya Pradesh, India – 452001.

Elixir Biopharma is registered under the jurisdiction of the Registrar of Companies (ROC), Gwalior.